emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide fumarate
emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide fumarate · EMTRICITABINE 200 mg/1; RILPIVIRINE HYDROCHLORIDE 25 mg/1; TENOFOVIR ALAFENAMIDE FUMARATE 25 mg/1 · Tablet · Rottendorf Pharma GmbH
NDC 49629-0017-01 · 30 TABLET in 1 BOTTLE, PLASTIC · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide fumarate (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Rottendorf Pharma GmbH | EMTRICITABINE 200 mg/1; RILPIVIRINE HYDROCHLORIDE 25 mg/1; TENOFOVIR ALAFENAMIDE FUMARATE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide fumarate — NDC 49629-0017-01," retrieved September 3, 2026, https://drugdashboards.com/drug/49629001701.
Free to cite with attribution — see how the data is put together.